Hyperfibrinolysis and Fibrinolysis Shutdown in Patients with Traumatic Brain Injury

Overview

Journal Sci Rep

Specialty Science

Date 2022 Nov 9

PMID 36352256

Authors

Ryuta Nakae

Yasuo Murai

Takeshi Wada

Yu Fujiki

Takahiro Kanaya

Yasuhiro Takayama

Go Suzuki

Yasutaka Naoe

Hiroyuki Yokota

Shoji Yokobori

Affiliations

Soon will be listed here.

Abstract

Traumatic brain injury (TBI) is associated with coagulation/fibrinolysis disorders. We retrospectively evaluated 61 TBI cases transported to hospital within 1 h post-injury. Levels of thrombin-antithrombin III complex (TAT), D-dimer, and plasminogen activator inhibitor-1 (PAI-1) were measured on arrival and 3 h, 6 h, 12 h, 1 day, 3 days and 7 days after injury. Multivariate logistic regression analysis was performed to identify prognostic factors for coagulation and fibrinolysis. Plasma TAT levels peaked at admission and decreased until 1 day after injury. Plasma D-dimer levels increased, peaking up to 3 h after injury, and decreasing up to 3 days after injury. Plasma PAI-1 levels increased up to 3 h after injury, the upward trend continuing until 6 h after injury, followed by a decrease until 3 days after injury. TAT, D-dimer, and PAI-1 were elevated in the acute phase of TBI in cases with poor outcome. Multivariate logistic regression analysis showed that D-dimer elevation from admission to 3 h after injury and PAI-1 elevation from 6 h to 1 day after injury were significant negative prognostic indicators. Post-TBI hypercoagulation, fibrinolysis, and fibrinolysis shutdown were activated consecutively. Hyperfibrinolysis immediately after injury and subsequent fibrinolysis shutdown were associated with poor outcome.

Citing Articles

Fibrinolytic Changes in Critical Illnesses: Is Fibrinolysis Shutdown a Specific Concept?.

Levy J, Iba T Juntendo Iji Zasshi. 2025; 70(6):416-419.

PMID: 39839999 DOI: 10.14789/ejmj.JMJ24-0035-P.

Systemic mechanisms of necrotic cell debris clearance.

Schuermans S, Kestens C, Marques P Cell Death Dis. 2024; 15(8):557.

PMID: 39090111 PMC: 11294570. DOI: 10.1038/s41419-024-06947-5.

Establishment and validation of a bad outcomes prediction model based on EEG and clinical parameters in prolonged disorder of consciousness.

Liu W, Guo Y, Xie J, Wu Y, Zhao D, Xing Z Front Hum Neurosci. 2024; 18:1387471.

PMID: 38952644 PMC: 11215084. DOI: 10.3389/fnhum.2024.1387471.

COVID-19: Not a thrombotic disease but a thromboinflammatory disease.

He S, Blomback M, Wallen H Ups J Med Sci. 2024; 129.

PMID: 38327640 PMC: 10845889. DOI: 10.48101/ujms.v129.9863.

Early prediction for massive fresh frozen plasma transfusion based on fibrinogen/fibrin degradation products and D-dimer in patients with blunt trauma: a single-center, retrospective cohort study.

Fukushima M, Kiguchi T, Ikegaki S, Inoue A, Nishioka N, Tateyama Y Eur J Trauma Emerg Surg. 2024; 50(2):603-610.

PMID: 38319351 DOI: 10.1007/s00068-024-02452-8.

References

Kuru Bektasoglu P, Koyuncuoglu T, Akbulut S, Akakin D, Peker Eyuboglu I, Erzik C . Neuroprotective Effect of Plasminogen Activator Inhibitor-1 Antagonist in the Rat Model of Mild Traumatic Brain Injury. Inflammation. 2021; 44(6):2499-2517. DOI: 10.1007/s10753-021-01520-0. View

Wada T, Gando S, Maekaw K, Katabami K, Sageshima H, Hayakawa M . Disseminated intravascular coagulation with increased fibrinolysis during the early phase of isolated traumatic brain injury. Crit Care. 2017; 21(1):219. PMC: 5568862. DOI: 10.1186/s13054-017-1808-9. View

Janssen K, Donders A, Harrell Jr F, Vergouwe Y, Chen Q, Grobbee D . Missing covariate data in medical research: to impute is better than to ignore. J Clin Epidemiol. 2010; 63(7):721-7. DOI: 10.1016/j.jclinepi.2009.12.008. View

Rossetto A, Vulliamy P, Lee K, Brohi K, Davenport R . Temporal Transitions in Fibrinolysis after Trauma: Adverse Outcome Is Principally Related to Late Hypofibrinolysis. Anesthesiology. 2021; 136(1):148-161. DOI: 10.1097/ALN.0000000000004036. View

Chapman M, Moore E, Moore H, Gonzalez E, Gamboni F, Chandler J . Overwhelming tPA release, not PAI-1 degradation, is responsible for hyperfibrinolysis in severely injured trauma patients. J Trauma Acute Care Surg. 2015; 80(1):16-23. PMC: 4688194. DOI: 10.1097/TA.0000000000000885. View

Gando S, Sawamura A, Hayakawa M . Trauma, shock, and disseminated intravascular coagulation: lessons from the classical literature. Ann Surg. 2011; 254(1):10-9. DOI: 10.1097/SLA.0b013e31821221b1. View

Karri J, Cardenas J, Matijevic N, Wang Y, Choi S, Zhu L . Early Fibrinolysis Associated with Hemorrhagic Progression Following Traumatic Brain Injury. Shock. 2017; 48(6):644-650. DOI: 10.1097/SHK.0000000000000912. View

Lustenberger T, Talving P, Kobayashi L, Inaba K, Lam L, Plurad D . Time course of coagulopathy in isolated severe traumatic brain injury. Injury. 2010; 41(9):924-8. DOI: 10.1016/j.injury.2010.04.019. View

Dietrich W, Alonso O, Halley M . Early microvascular and neuronal consequences of traumatic brain injury: a light and electron microscopic study in rats. J Neurotrauma. 1994; 11(3):289-301. DOI: 10.1089/neu.1994.11.289. View

10.

Jennett B, Snoek J, Bond M, Brooks N . Disability after severe head injury: observations on the use of the Glasgow Outcome Scale. J Neurol Neurosurg Psychiatry. 1981; 44(4):285-93. PMC: 490949. DOI: 10.1136/jnnp.44.4.285. View

11.

Talving P, Benfield R, Hadjizacharia P, Inaba K, Chan L, Demetriades D . Coagulopathy in severe traumatic brain injury: a prospective study. J Trauma. 2009; 66(1):55-61. DOI: 10.1097/TA.0b013e318190c3c0. View

12.

Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y . Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010; 376(9734):23-32. DOI: 10.1016/S0140-6736(10)60835-5. View

13.

Schwarzmaier S, Kim S, Trabold R, Plesnila N . Temporal profile of thrombogenesis in the cerebral microcirculation after traumatic brain injury in mice. J Neurotrauma. 2009; 27(1):121-30. DOI: 10.1089/neu.2009.1114. View

14.

Tian H, Chen H, Wu B, Cao H, Xu T, Hu J . D-dimer as a predictor of progressive hemorrhagic injury in patients with traumatic brain injury: analysis of 194 cases. Neurosurg Rev. 2010; 33(3):359-65. DOI: 10.1007/s10143-010-0251-z. View

15.

Hukkelhoven C, Steyerberg E, Rampen A, Farace E, Habbema J, Marshall L . Patient age and outcome following severe traumatic brain injury: an analysis of 5600 patients. J Neurosurg. 2003; 99(4):666-73. DOI: 10.3171/jns.2003.99.4.0666. View

16.

Stein S, Graham D, Chen X, Smith D . Association between intravascular microthrombosis and cerebral ischemia in traumatic brain injury. Neurosurgery. 2004; 54(3):687-91. DOI: 10.1227/01.neu.0000108641.98845.88. View

17.

Nakae R, Murai Y, Morita A, Yokobori S . Coagulopathy and Traumatic Brain Injury: Overview of New Diagnostic and Therapeutic Strategies. Neurol Med Chir (Tokyo). 2022; 62(6):261-269. PMC: 9259082. DOI: 10.2176/jns-nmc.2022-0018. View

18.

Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y . The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet. 2011; 377(9771):1096-101, 1101.e1-2. DOI: 10.1016/S0140-6736(11)60278-X. View

19.

Harhangi B, Kompanje E, Leebeek F, Maas A . Coagulation disorders after traumatic brain injury. Acta Neurochir (Wien). 2008; 150(2):165-75. DOI: 10.1007/s00701-007-1475-8. View

20.

Powers A, Pinto M, Tang O, Chen J, Doberstein C, Asaad W . Predicting mortality in traumatic intracranial hemorrhage. J Neurosurg. 2019; 132(2):552-559. DOI: 10.3171/2018.11.JNS182199. View